Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

Opinion
Video

Panelists discuss the adverse effects experienced by a patient undergoing treatment with capecitabine (Xeloda), trastuzumab (Herceptin), and tucatinib (Tukysa), along with the strategies employed to manage those adverse effects, while also addressing patient follow-up procedures, including the frequency of visits, typical labs and imaging ordered, concerning symptoms and lab results, and the outcomes of the patient's most recent follow-up appointment.

  1. Dr Iyengar asks Dorian Nygard: What side adverse effects have you experienced with your current treatment (capecitabine [Zeloda], trastuzumab [Herceptin], and tucatinib [Tukysa])?
    1. What strategies have you found to be most helpful in managing these side adverse effects?
  2. Dr Iyengar asks Odessa Williams: Describe patient follow-up procedures in your practice.
    1. How often do you see your patients for follow-up at your institution
    2. What labs and imaging are typically ordered and at what frequency?
    3. During follow-up, what symptoms or labs are most concerning to you?
  3. Dr Iyengar asks Dorian Nygard: What was the outcome of your most recent follow-up appointment?
Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts in this video
Related Content
Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective

Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective

ONCOLOGY Staff
December 29th 2024
Article

In a From All Angles program, a patient and her treating physician spoke about the initial diagnosis, care coordination, communication, and the adverse effects observed.